Catalyst Wire Dossier Catalyst Wire Dossier

Fluvestrant

fluvestrant
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fluvestrant, covering 2020-06-23 to 2020-06-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Fluvestrant Combined With Oral Vinorelbine in Hormone Receptor-positive Advanced Breast Cancer [Phase 2]

See pricing